$BLND

Haveli Investments, L.P. purchased $2.0M of BLND (indirect holdings)

Haveli Investments, L.P. purchased 1,156,928 indirectly-held shares of Blend Labs, Inc. (BLND) at an average of $1.72 ($1.70–$1.74, $1.99M total) across 3 trades over 2026-06-11 to 2026-06-15.

Original reporting
SEC EDGAR · Haveli Investments, L.P.
Published Jun 15, 2026, 10:17 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 15, 2026, 10:22 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$BLND
Bullish
medium confidence
Mentioned
$BLND
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BLNDBullishLow
01

Why it matters

A 10% owner/director reported indirect open-market purchases totaling ~$1.99M at an average ~$1.7213 per share, with holdings after the transaction at 18,693,657 shares.

02

Market read

Traders may treat the filing as a modest sentiment input, but it lacks fundamental new information beyond the ownership change.

03

What to watch

Form 4 timing spans multiple days and includes a range of prices; without context on prior holdings/trading intent, the signal strength is uncertain.

Relevance 7/10Novelty 8/10Timing: Filed 2026-06-15 (covers purchases 2026-06-11 to 2026-06-15).

Background

The article is an SEC Form 4 insider transaction disclosure for Blend Labs, Inc. (BLND).

Company-level read

Ticker impact

$BLNDBullishMedium confidence
Context

Haveli Investments, L.P. (10% owner/director) reported an open-market purchase of 1,156,928 BLND shares for ~$1.99M via SEC Form 4.

Expected impact

Likely limited near-term impact; any effect should be small and fade unless followed by additional disclosures or company-specific news.

Evidence & confidence

The filing is a fresh Form 4 and shows sizable buying, but it does not include new company fundamentals (no guidance, deal, or regulatory action).

Market effects

No clear sector read-through; this is a single-issuer ownership transaction.

None indicated.

None indicated.

Counterpoint

Buying under a 10b5-1 plan is explicitly denied here, but the absence of a plan does not guarantee conviction; it could reflect liquidity/portfolio rebalancing.

Key entities

  • Blend Labs, Inc.

    Subject of the SEC Form 4 insider transaction disclosure (BLND).

  • Haveli Investments, L.P.

    10% owner/director reporting indirect open-market purchases of BLND shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BLNDMed

British Land reports strong Q1 leasing momentum By Investing.com

British Land reported Q1 FY2027 leasing of 567,000 sq ft, completed at 4.8% above estimated rental value and 8.7% above prior passing rents. An extra 1.1m sq ft is under offer. Near-full occupancy was noted for retail parks and London Urban Logistics. Disposals totaled £83m at 3.2% net initial yield. FY2027 underlying EPS guidance of at least 30.5p was kept.